.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Deloitte
Merck
McKesson
Boehringer Ingelheim
Colorcon
Teva
US Army
Fuji
Mallinckrodt

Generated: June 26, 2017

DrugPatentWatch Database Preview

OLANZAPINE Drug Profile

« Back to Dashboard

What is the patent landscape for Olanzapine, and when can generic versions of Olanzapine launch?

Olanzapine is a drug marketed by Teva Pharms, Ivax Pharms Inc, Aurobindo Pharma Ltd, Par Pharm, Ajanta Pharma Ltd, Torrent Pharms Llc, Qilu Pharm Co Ltd, Jubilant Generics, Dr Reddys Labs Ltd, Invagen Pharms, Torrent Pharms Ltd, Orchid Hlthcare, Sun Pharm Inds, Luitpold, Barr Labs Inc, Macleods Pharms Ltd, Apotex Inc, Mylan Pharms Inc, Sandoz Inc, Alkem Labs Ltd, and Sandoz. and is included in thirty-four NDAs.

The generic ingredient in OLANZAPINE is fluoxetine hydrochloride; olanzapine. There are twenty-seven drug master file entries for this compound. Five suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the fluoxetine hydrochloride; olanzapine profile page.

Summary for Tradename: OLANZAPINE

Patents:0
Applicants:21
NDAs:34
Suppliers / Packagers: see list38
Bulk Api Vendors: see list92
Clinical Trials: see list388
Patent Applications: see list5,206
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OLANZAPINE at DailyMed

Pharmacology for Tradename: OLANZAPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Macleods Pharms Ltd
OLANZAPINE
olanzapine
TABLET, ORALLY DISINTEGRATING;ORAL203044-001Feb 20, 2015ABRXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
OLANZAPINE
olanzapine
TABLET;ORAL076866-002Apr 23, 2012ABRXNoNo► Subscribe► Subscribe
Invagen Pharms
OLANZAPINE
olanzapine
TABLET;ORAL203333-001Mar 15, 2016ABRXNoNo► Subscribe► Subscribe
Ajanta Pharma Ltd
OLANZAPINE
olanzapine
TABLET, ORALLY DISINTEGRATING;ORAL204320-002May 30, 2017ABRXNoNo► Subscribe► Subscribe
Invagen Pharms
OLANZAPINE
olanzapine
TABLET, ORALLY DISINTEGRATING;ORAL203456-001Mar 16, 2016ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
US Army
Dow
Argus Health
Fuji
Baxter
Accenture
Julphar
Johnson and Johnson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot